• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Update of Administrative Measures for the Clinical Use of Medical Devices

Update of Administrative Measures for the Clinical Use of Medical Devices

Wednesday, 24 March 2021 / Published in Medical Device, News, NMPA Registration in China

Update of Administrative Measures for the Clinical Use of Medical Devices

On February 4, 2021, the NHC (National Health Commission) announced (No.8-2021) the implementation of the Administrative Measures for the Clinical Use of Medical Devices coming into force from March 1, 2021 onwards. This legislation formalizes as a higher level regulation of the previously implemented Code.

Background

The Code of Practice for the Safe and Clinical Use of Medical Devices was published (No.4-2010) in 2010. Based on the experiences gained from the management of clinical use of medical device in the past, the new measure enhances the safety and effective use of medical devices and acts as a regulatory guidance for health authorities.

Purpose of the New Measure

  • Strengthen the management of the clinical use of medical devices
  • Ensure the safe and effective clinical use of medical devices
  • Clarify the roles and responsibilities between the national health authorities and local health authorities in terms of the supervision and the management of medical devices
  • Clarify the responsibilities of the person in charge of the medical institution

Requirements for Medical Institutions

  • Establish a risk management system for the clinical use of medical devices
  • Implement a monitoring and reporting system for priority medical devices (e.g., life-support devices)
  • Keep medical records for large, implantable and interventional medical devices
  • Carry out evaluations on the clinical use of medical devices
  • Terminate all related operations of the medical device if any safety risks are identified and call for maintenance

Supervision and Management

  • Medical institutions will be penalized correspondingly for violating the newly addressed measures

 By Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Clinical Use of Medical Devices

What you can read next

NMPA Temporary Rearrangements to Facilitate Registrations Affected by COVID-19
Measures for Cosmetics Adverse Reaction
Cosmetics Ingredient Submission Code as New Trend Requirement in 2023
Digital Health Alert: 3 New China Regulatory Guidelines Released

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP